Business Issues/Benchmarks: Page 80

North Dakota Voters Reject Adult-Use Cannabis

Cannabis legalization takes a back seat as Measure 2 is defeated.

Arkansas Voters Come Out in Opposition to Cannabis Legalization

A wide margin of defeat held steady throughout the night, as Arkansas election returns held legalization efforts at bay.

Where Cannabis Ballot Measures Polled Entering Election Day

Maryland and Missouri show promise for passage; Arkansas’ reform appears grim; South Dakota is a toss-up; and North Dakota is a bit unknown.

National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed

The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.

Lowell Farms Tabs Two for Board of Directors

The California cannabis brand appointed Summer Frein and Ann Lawrence to its board of directors.

Tilray Brands Acquires Montauk Brewing Company

Tilray expands and strengthens its U.S. footprint with acquisition of the fastest growing craft beer brand and top craft brewer in Metro New York.

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

Cresco Labs, Columbia Care Announce Divestiture in 3 Markets to Sean “Diddy” Combs

Cresco and Columbia Care’s agreement to sell New York, Illinois and Massachusetts assets marks major steps toward closing their own M&A deal.

Playing Favorites

Factors that influence where cannabis consumers shop often boil down to accessibility.

Tilray Brands, Charlotte’s Web Announce Strategic Alliance in Canada

Tilray will launch Charlotte’s Web proprietary full-spectrum hemp CBD products across Canada in 2023.

Missouri Secretary of State a ‘No’ Vote on Adult-Use Cannabis

Jay Ashcroft, who certified the state’s 2022 ballot measure, does not support Amendment 3, but a new poll shows the proposal’s support holding steady.

Will Biden’s Order to Review Cannabis’s CSA Scheduling Impact Publicly Traded Cannabis Companies?

Cannabis experts and publicly traded operators weigh in on the announcement’s effects on stocks last month, as well what the future could hold if cannabis is either descheduled or rescheduled from its current Schedule I status in the Controlled Substances Act.

Previous Page

Page 80 of 516

Next Page